Search clinical trials for: ritonavir-boosted fosamprenavir

Total 1389 results

Zhongnan Hospital

Unknown

Comparing Preoperative Short-course Radiotherapy With or Without Local Boost for Rectal Cancer

Rectal Cancer
Maruho Europe Limited

Completed

Drug-Drug Interaction Study: ASP2151 and Ritonavir

Healthy

United Kingdom
Pfizer

Completed

A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.

Healthy Participants

China
Hoffmann-La Roche

Completed

A Study of Danoprevir in Healthy Volunteers And Patients With Hepatic Impairment

Healthy Volunteer

Slovakia, United States, Czech Republic
Stanford University

Recruiting

Communication and Marketing of School Meals

Food Insecurity

United States
Centre Francois Baclesse, Luxembourg

Active, not recruiting

IMRT Followed by CyberKnife Boost Focused on the Gross Residual Pelvic Tumor Volume (Boost_Pelvis)

Pelvis Tumors

Luxembourg
Dr. Patrick Cheung

Active, not recruiting

Hypofractionated Boost vs Conventionally Fractionated Boost for Localized High Risk Prostate Cancer

Prostate Cancer

Canada
Emory University

Completed

Hypofractionated Radiotherapy in Breast Cancer

Inflammation | Cancer, Breast

United States
University of Exeter
Devon and Cornwall Police; Dorset Police

Completed

Physical Activity Wearables in the Police Force: The PAW-Force Trial

Physical Activity | Health Behavior

United Kingdom
Oregon Research Institute

Completed

Building Outcomes With Observation-Based Supervision: An FFT Effectiveness Trial (BOOST)

Substance Abuse | Delinquency | Self Destructive Behavior

United States
Capital Medical University

Active, not recruiting

Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer

Breast Cancer | Surgery | Adjuvant Radiotherapy

China
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Terminated

Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients

Nonsmall Cell Lung Cancer Stage III | Nonsmall Cell Lung Cancer, Stage II

United States
Royal North Shore Hospital

Completed

Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate Cancer (BOOSTER)

Prostate Cancer

Australia
Juravinski Cancer Center
Hamilton Health Sciences Corporation; Juravinski Cancer Centre Foundation

Unknown

Stereotactic Body Radiotherapy Boost After Palliative Radiotherapy for Spinal Cord Compression (CRUSSH)

Spinal Cord Compression | Cauda Equina Syndrome | Stereotactic Body Radiotherapy

Canada
Ronald McGarry

Completed

Stereotactic Body Radiation Therapy in Stage II/III Non Small Cell Lung Cancer

Lung Cancer

United States
NYU Langone Health

Completed

Prospective Trial of Two Prone Breast Radiotherapy Techniques With Randomization to Concurrent Versus Weekly Boost

Breast Cancer

United States
Hoffmann-La Roche

No longer available

A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

Postmenopausal Osteoporosis

Taiwan
National Institute of Allergy and Infectious Diseases...

Completed

A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines

HIV

United States, South Africa, Thailand, Brazil
HaEmek Medical Center, Israel
AbbVie

Completed

Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B

HCV Coinfection

Israel
Institut de Médecine et d'Epidémiologie Appliquée...
Abbott

Completed

Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients (KALESOLO)

HIV Infections

France
Abbott

Completed

Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir

HCV Infection

United States
Accare

Recruiting

A Randomized Controlled Trial on Brief Behavioral Parent Training (PAINT-GGZ)

Behavioral Symptoms | Behavior Problems | Behavioral Problems | Disruptive Behavior | Problem Behaviors | Behavioral Difficulties

Netherlands
Assistance Publique - Hôpitaux de Paris
IREIVAC/COVIREIVAC Network

Active, not recruiting

Randomized, Single-blinded, Multicenter Trial Comparing the Immune Response to a 2nd Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNTech) or Sanofi /GSK B.1.351 Adjuvanted Vaccine in Adults (COVIBOOSTAnci1)

COVID-19 Vaccines

France
Amsterdam UMC, location VUmc
Boehringer Ingelheim; Abbott

Unknown

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

HIV Infections | HIV-Associated Lipodystrophy Syndrome

Finland, Netherlands, Spain, United Kingdom
CHU de Quebec-Universite Laval
Canadian Institutes of Health Research (CIHR); Canadian Cancer Society (CCS)

Recruiting

Implementation of CBT-I in Cancer Clinics

Insomnia

Canada
University of Cincinnati

Completed

Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study

HIV Infections

United States
AbbVie

Terminated

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma (GEODE - I)

Chronic Hepatitis C Infection
Abbott

Completed

Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects

Human Immunodeficiency Virus Infections

United States, Australia, Belgium, Canada, Czech Republic, France, Germany, Greece, Ireland, Italy, Netherlands, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Switzerland, Taiwan, United Kingdom
Bristol-Myers Squibb

Completed

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

HIV Infections

United States
Pfizer

Suspended

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

COVID-19

United States, United Kingdom, Japan, South Africa, Bulgaria, Puerto Rico, Mexico, Hungary
AbbVie

Withdrawn

Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD) (GIFT-R)

Chronic Hepatitis C Virus
Hoffmann-La Roche

Completed

A Study of Drug-Drug Interaction Between Darunavir and Danoprevir Administered Together With Low-Dose Ritonavir in Healthy Volunteers

Healthy Volunteer

United States
The HIV Netherlands Australia Thailand Research...
Chulalongkorn University; UMC St. Radboud, Nijmegen, The Netherlands

Completed

Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children

HIV-1 Infections

Thailand
Boehringer Ingelheim

Terminated

Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

HIV Infections

United States, Argentina, Brazil, France, Germany, Italy, Spain
Tibotec Pharmaceuticals, Ireland

Completed

TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted Conditions

Healthy

Germany
Boehringer Ingelheim

Completed

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

HIV Infections

Germany
St Stephens Aids Trust

Completed

Double Protease Inhibitor to Darunavir Switch Study

HIV Infections

United Kingdom
Abbott

Completed

A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

HIV Infections

United States, France, Spain
National Institute of Allergy and Infectious Diseases...

Completed

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

HIV Infections | Lipodystrophy | Wasting Disease

United States
ANRS, Emerging Infectious Diseases
Abbott

Completed

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

HIV Infections

France
Bristol-Myers Squibb

Completed

Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone

HIV Infections

United States
Radboud University Medical Center

Not yet recruiting

Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided Radiotherapy (AFFIRM)

Prostate Cancer | Prostate Neoplasm

Netherlands
Centre hospitalier de l'Université de Montréal...

Recruiting

Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy (fBTsRT)

Prostate Cancer

Canada
Virginia Commonwealth University

Withdrawn

Thermic Effect of Feeding in Cystic Fibrosis

Cystic Fibrosis

United States
University Hospital Schleswig-Holstein
University of Luebeck

Completed

Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer

Breast Cancer After Breast Conserving Surgery Indicating Postoperative Radiotherapy With Boost

Germany
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)

Uterine Neoplasms | Vaginal Neoplasms | Cervix Neoplasms

Canada
Shandong Provincial Hospital
Gansu Provincial Hospital; The Affiliated Hospital Of Southwest Medical University and other collaborators

Recruiting

A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection

COVID-19

China
Vigonvita Life Sciences

Completed

Efficacy and Safety of JT001 (VV116) Compared With Paxlovid

COVID-19

China
Pfizer

Completed

Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Formulation

Bioavailability

United States
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

HIV Infections

United States, Puerto Rico, Brazil

3

Subscribe